DURHAM, N.C. (AP) _ Argos Therapeutics Inc. (ARGS) on Thursday reported a loss of $6.1 million in its third quarter.
On a per-share basis, the Durham, North Carolina-based company said it had a loss of 10 cents.
The biotechnology company posted revenue of $53,500 in the period. Its adjusted revenue was $53,000.
The company's shares closed at 19 cents. A year ago, they were trading at $4.35.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARGS at https://www.zacks.com/ap/ARGS
Find out what activities and attractions make these 20 cities and town some of the best places to retire around the world
Generics are a great way to save money in lots of cases, but here is a look at some clear exceptions